HB 1743 -- Pharmacy
Co-Sponsors: Foley, Naeger
This bill contains provisions relating to the practice of
pharmacy and the State Board of Pharmacy.
(1) The definition of the "practice of pharmacy" is revised to
include the implementation of orders relating to drug therapy
and the administration of drugs and devices pursuant to
(2) Pharmacists are allowed to consult with patients and health
practitioners regarding therapeutic values, hazards, and adverse
reactions of drugs; the monitoring of drug use; and the
initiating or modifying of drug therapy according to guidelines
and protocols established by those authorized to prescribe drugs.
(3) Pharmacists may, after diagnosis and referral of a patient
by a practitioner authorized to prescribe drugs, engage in
initiating or modifying drug therapy, as long as the therapy is
in accordance with the guidelines and protocols established by
the referring practitioner.
(4) Pharmacists who have completed a graduate level program
from a nationally accredited college or its equivalency issued
by a nationally recognized professional organization and
approved by the board may, after diagnosis and referral of the
patient by a licensed physician, dentist, podiatrist,
veterinarian, or optometrist, independently engage in the
initiating, modifying, or prescribing of drugs and drug therapy
as long as it is within the written guidelines, collaborative
practice arrangements, or protocols established by the
pharmacist's practice. The practice locations of the pharmacist
and the practitioner engaging in such modification practices
must be within a 50-mile radius of each other.
(5) The Board of Pharmacy may file complaints with the
Administrative Hearing Commission against pharmacists for the
unauthorized use or consumption of controlled substances.
(6) Authority is given to the board to issue letters of
reprimand, censure, or warning for drug or alcohol abuse,
conviction of a crime, fraud, and incompetency. Provisions are
made to allow licensees' to respond to charges before the
Administrative Hearing Commission.
(7) The board may levy a fine of up to $10,000 against any
person who offers to or engages in the practices of a drug
distributor without being duly licensed.
Missouri House of Representatives' Home Page
Last Updated October 5, 2000 at 11:34 am